Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
SEC Form 4
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2309 per share on February 10, 2025, according to a Form 4 filing.
Summary
- On February 10, 2025, the W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock.
- The sale price was $82.2309 per share.
- Following the transaction, the Trust beneficially owns 48,191,195 shares of Kellanova.
- The sales were made pursuant to trading instructions given on May 7, 2024, intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction appears to be part of a pre-planned strategy (Rule 10b5-1) and doesn't necessarily reflect a change in the Trust's view of the company's prospects.
Industry Context
Sales by major shareholders are common and can be for a variety of reasons, including diversification or philanthropic purposes. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on current market conditions.
Stakeholder Impact
- The sale of shares by a major shareholder like the W.K. Kellogg Foundation Trust could have a minor negative impact on investor sentiment in the short term.
- However, the pre-planned nature of the sale (Rule 10b5-1) may mitigate concerns.
Key Dates
| Date | Description |
|---|---|
| August 30, 2017 | Date of Power of Attorney granted to Craig R. Carberry. |
| May 7, 2024 | Date of trading instructions given by the W.K. Kellogg Foundation Trust. |
| February 10, 2025 | Date of the transaction (sale of shares). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.